Pfizer promotes Patrick van der Loo to Regional President for Africa and Middle East

Pfizer announced the appointment of Patrick van der Loo as Regional President for Africa and Middle East region, AfME. Patrick’s Pfizer experience spans more than 20 years in leadership roles with multiple successes across geographies.  In his new role as Regional President for AfME, Patrick will lead commercial operations to bring scientific breakthroughs in vaccines, oncology, rare diseases, internal medicine, hospitals, and inflammation and immunology, to serve patients.

Patrick has managed some of Pfizer’s largest therapeutic areas in cardiovascular and neuroscience globally and led the commercial development efforts of a 500+ molecule business. In his previous role, Patrick served as the Developed Asia Cluster Lead and General Manager for Pfizer’s Hospital Business Unit, responsible for leading and executing Pfizer’s commercial and cultural strategy in Japan, Korea, Australia, and New Zealand. Before this role, Patrick worked as the Emerging Asia Cluster Lead for the Pfizer Essential Health business.

Commenting on his appointment, Patrick said: “Pfizer has been operating for over 60 years in AfME. I look forward to continuing this journey and bringing our breakthroughs to address unmet patient needs. My top priority will remain to work with our teams to ensure greater access to our medicines across our strategic therapeutic areas. We will seek even stronger collaboration with healthcare professionals, communities, and governments to change the lives of millions of people and protect them from tomorrow’s health threats.”